Updates are available Correction dated 2014-08-28

Click to view Correction: https://doi.org/10.1007/s10549-014-3107-3

Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer

Crossref DOI link: https://doi.org/10.1007/s10549-014-3042-3

Published Online: 2014-07-11

Published Print: 2014-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark